Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015

Print

Search Results for 'Custom Manufacturing'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published May 12, 2015
Will support commercial-scale ADC manufacturing Read More »
Published May 12, 2015
To bolster clinical and commercial bulk drug production and fill/finish for gene therapies Read More »
Newsmakers: Gilles Cottier
Published May 6, 2015
Supporting Biologics Development Read More »
Newsmakers: Margaret Timony
Published March 6, 2015
What’s Happening at DCAT Week ’15? Read More »
Published February 17, 2015
To provide custom biomanufacturing for commercial production Read More »
Published September 25, 2014
Will align conjugation and manufacture of drug linkers with sterile fill/finish services Read More »
Published July 24, 2014
Opens new FDA-registered facility in Bangor, PA Read More »
Published July 8, 2014
Lonza veteran brings extensive experience Read More »
Published May 20, 2014
Enhances lean manufacturing platform Read More »
Published May 7, 2014
Will align Pharmorphix and BioTools for comprehensive chiral technology services Read More »
By Kristin Brooks
Published January 23, 2014
Pharma & Biotech sales down 8% Read More »
By Kristin Brooks
Published January 16, 2014
Van Nieuwenhove brings extensive experience Read More »
Published December 4, 2013
To provide process development activities Fc-fusion protein Read More »
Published October 22, 2013
Audits demonstrate custom manufacturing capabilities Read More »
Published October 15, 2013
Invests in commercial-scale ADC and expands HPAPI manufacturing and storage Read More »
Picking Tomorrow’s Winners
By Peter Pollak and Andrew Badrot, CMS Pharma
Published October 9, 2013
Review the business development cycle in the custom manufacturing industry and assess risks associated with pharmaceutical fine chemicals manufacturing Read More »
Published September 9, 2013
body { background:none;background-color:#e5e5e5; } table { background-color:#FFFFFF; } #menu { background-color:#FFFFFF; }   AbbVie… Read More »
Published June 4, 2013
Will be used to maximize MAb production and other r-proteins Read More »
Published March 5, 2013
Adds Dry Powder Manufacturing Capabilities Read More »
Published October 8, 2012
Will leverage enzyme technologies to manufacture APIs Read More »
Future Bio-Capacity Constraints
By Eric S. Langer, BioPlan Associates, Inc.
Published September 6, 2012
Top 10 factors from a new survey Read More »
Published July 17, 2012
DSM will provide process development and cGMP manufacture of RECEPTA antibody Read More »
Published June 11, 2012
Rodwell appointed to lead the method development team Read More »
Published June 4, 2012
Gains entry into custom sterile filling market Read More »
By Andrew Badrot
Published May 15, 2012
What does the Kensey Nash deal say about DSM's growth strategy? Read More »
Published April 12, 2012
Lonza to produce commercial material at its facility in the Czech Republic Read More »
Published April 3, 2012
Expands buffer production capacity, increases raw materials portfolio Read More »
Published March 2, 2012
Lonza will produce Phase I material at Slough site Read More »
By Andrew Badrot
Published February 8, 2012
Was the departure of Lonza's CEO too hasty? Read More »
Published January 31, 2012
Indoco will manufacture eight APIs for DSM Read More »
Published January 25, 2012
board made decision to replace Borgas in the last 48 hours Read More »
API Manufacturing: Facts and Fiction
By Peter Pollak, Andrew Badrot and Rolf Dach
Published January 23, 2012
Have costs of Chinese & Indian fine chemical producers closed in on European & U.S. Levels? Read More »
Published October 26, 2011
Verona, WI site provides commercial scale HPAPI Read More »
The China Challenge
By Andrew Badrot
Published October 11, 2011
Balance short-term profits and long-term competitive advantage Read More »
By Andrew Badrot
Published October 5, 2011
Unique skillsets and assets explain why BI is primed for success in this burgeoning market Read More »
By Andrew Badrot
Published September 19, 2011
High Labor Cost Countries are making a comeback against low-cost counterparts Read More »
By Gil Roth
Published August 22, 2011
Buys suite of iontophoretic technology from Travanti Pharma Read More »
By Andrew Badrot
Published June 1, 2011
China Vs. India in the API Race? Andrew Badrot, CMS Pharma Separating the noteworthy news from the noise is not always as straightforward as one may think. And sometimes, two separate newsfeeds get a new meaning when pieced together. Let me expla… Read More »
Vaccines & CMOs
By Gil Roth
Published November 9, 2010
What have we learned from H1N1? Read More »
Published February 16, 2010
Albemarle Corp. has entered a partnership with PharmaCore to provide manufacturing capabilities for customers with projects that require high volume capacity. Read More »
By S. Harachand
Published September 3, 2009
India's CMO business grows at 3X the global rate Read More »
Biopharma CMO Market Report
By William Downey
Published April 30, 2008
Optimism is high among bio-contract manufacturers Read More »
By S. Harachand
Published February 25, 2008
Oral dosage business sees surge coming Read More »
By George Karris
Published August 22, 2005
How will changes in India and China affect API outsourcing? Read More »
By Dr. Enrico T. Polastro
Published August 22, 2005
When will we see legal generics of top biopharmaceuticals? Read More »
By Gil Roth
Published August 22, 2005
Editor Gil Roth profiles the top companies in the various pharma and biopharma outsourcing arenas, with analyst perspective from investment analyst Michael Martorelli. Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On